Back

New insights on CETP inhibitors from genetic research and clinical trials

27 August 2023 (10:30 - 10:45)
Organised by: Logo
Congress Presentation Part of: Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success? Lipid-Lowering Agents Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor John Kastelein

Antoni van Leeuwenhoek Hospital (AVL), Amsterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Introduction
Professor E. Stroes (Amsterdam, NL)
Slides Video
Presentation thumbnail
Unmet needs in lowering LDL-c: barriers to goal attainment and need for innovative targets
Professor S. Nicholls (Melbourne, AU)
Slides Video
Presentation thumbnail
Exploring the role of novel CETP inhibitors in lipid management
Professor R. Mehran (New York City, US)
Slides Video
Presentation thumbnail
Discussion
Professor E. Stroes (Amsterdam, NL) Professor S. Nicholls (Melbourne, AU) Professor J. Kastelein (Amsterdam, NL) Professor R. Mehran (New York City, US)
Video

Access the full session

Session thumbnail
Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?
Video

The Event

Event poster

ESC Congress 2023

27 August 2023 10:30 CET
You may be interested in
thumbnail
Congress Presentation
What do we know now that could have changed the history of CETP Inhibition? Genetics and biology
thumbnail
Congress Session
Role of CETP inhibitors in cardiovascular risk reduction: will lessons from the past lead to future success?
thumbnail
Congress Session
Innovating the clinical management of LDL-c: exploring CETP as therapeutic target

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources